Relationship between prothrombin time international normalized ratio and thrombo test (%)

Journal of Cardiology

Volumn 38, Issue 6, 2001, Pages 327-335

  Numata, Yuichi ^a   Ogata, Yasuhiro ^a   Arao, Kenshiro ^a   Mizumasa, Yutaka ^a   Wakita, Tomio ^a   Haruguchi, Hiroshi ^a   Araki, Hiroshi ^a   Tsuji, Takeshi ^a   Mawatari, Koshi ^a   Shimada, Kazuyuki ^a  

^a JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

Author keywords

Anticoagulants (warfarin); Blood coagulation (prothrombin time international normalized ratio, thrombo test)

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANALYTIC METHOD; ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; DATA ANALYSIS; FEMALE; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PROTHROMBIN TIME; REGRESSION ANALYSIS; THROMBOSIS; THROMBOTEST; VALIDATION PROCESS;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION TESTS; CORONARY THROMBOSIS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROTHROMBIN TIME; REFERENCE STANDARDS; REGRESSION ANALYSIS; WARFARIN;

EID: 0035687001     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Thirty-third report
2. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control
3. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study
4. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
5. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
6. Stroke Prevention in Atrial Fibrillation Study: Final results
7. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
8. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
9. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications
10. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community
11. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation
12. National patterns of warfarin use in atrial fibrillation
13. Thrombotest a new method for controlling anticoagulant therapy
14. Clinical significance of thrombotest and PT-INR in monitoring the oral anticoagulant therapy
15. Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: A preliminary report from a single institution using conversion from thrombotest to PTINR